Ying Yuan
The University of Texas MD Anderson Cancer Center(US)Hangzhou Medical College(CN)
Publications by Year
Research Areas
Colorectal Cancer Treatments and Studies, Genetic factors in colorectal cancer, Gastric Cancer Management and Outcomes, Cancer Immunotherapy and Biomarkers, Nonmelanoma Skin Cancer Studies
Most-Cited Works
- → Effect of Fruquintinib vs Placebo on Overall Survival in Patients With Previously Treated Metastatic Colorectal Cancer(2018)383 cited
- → LncRNA PCNAP1 modulates hepatitis B virus replication and enhances tumor growth of liver cancer(2019)184 cited
- → Surufatinib in advanced extrapancreatic neuroendocrine tumours (SANET-ep): a randomised, double-blind, placebo-controlled, phase 3 study(2020)182 cited
- → Surufatinib in advanced pancreatic neuroendocrine tumours (SANET-p): a randomised, double-blind, placebo-controlled, phase 3 study(2020)180 cited
- → Tislelizumab in Chinese patients with advanced solid tumors: an open-label, non-comparative, phase 1/2 study(2020)159 cited
- → Silencing SOX2 Induced Mesenchymal-Epithelial Transition and Its Expression Predicts Liver and Lymph Node Metastasis of CRC Patients(2012)153 cited